Skip to main content
. 2020 Apr 6;2020:7979353. doi: 10.1155/2020/7979353

Table 1.

Baseline characteristics of enrolled patients with CAP in ED.

All cohort Death Survival P ICU admission Non-ICU admission P
N (%) 336 89 (26.5) 247 (73.5) 61 (18.2) 275 (81.8)
Age (yrs) 76 (61, 84) 78 (67, 85) 75 (61, 83) 0.136 81 (70, 88) 74 (61, 83) 0.003
Male, n (%) 213 (63.4) 56 (62.9) 157 (63.6) 0.914 40 (65.6) 173 (62.9) 0.696
Comorbidities, n (%)
 COPD 40 (11.9) 12 (13.5) 28 (11.3) 0.592 16 (26.2) 24 (8.7) <0.001
 CDVD 48 (14.3) 18 (20.2) 30 (12.1) 0.062 14 (23.0) 34 (12.4) 0.033
 CBVD 88 (26.2) 28 (31.5) 60 (24.3) 0.187 18 (29.5) 70 (25.5) 0.515
 Diabetes 77 (22.9) 31 (34.8) 46 (18.6) 0.002 24 (39.3) 53 (19.3) 0.001
 CRD 30 (8.9) 9 (10.1) 21 (8.5) 0.648 8 (13.1) 22 (8.0) 0.205
 HBD 24 (7.1) 5 (5.6) 19 (7.7) 0.515 4 (6.6) 20 (7.3) 0.844
 Healthy 28 (8.3) 6 (6.7) 22 (8.9) 0.526 8 (13.1) 20 (7.3) 0.135
Laboratory results
 WBC (×109/L) 10.0 (6.7, 14.1) 11.0 (6.7, 15.9) 9.8 (6.8, 13.9) 0.406 11.7 (7.5, 15.9) 9.7 (6.6, 13.9) 0.046
 HGB (g/L) 126 (115, 137) 123 (111, 134) 127 (117, 138) 0.125 123 ± 22 127 (117, 138) 0.367
 HCT (%) 36.9 (31.8, 40.8) 34.7 ± 9.1 37.3 (32.9, 40.9) 0.037 35.5 ± 9.3 37.3 (32.5) 0.368
 PLT (×109/L) 184 (131, 251) 163 (123, 249) 191 (136, 251) 0.311 155 (123, 230) 191 (137, 254) 0.116
 ALB (g/L) 36.2 (32.1, 39.1) 34.0 ± 5.9 36.7 (33, 39.3) 0.001 34.3 ± 6.0 36.5 (32.5, 39.1) 0.044
 CREA (μmol/L) 80.5 (60.8, 114.3) 92 (63.6, 140) 75.9 (60.4, 105.8) 0.011 95.5 (74.6, 150) 75.9 (60.2, 105) <0.001
 BUN (mmol/L) 7.4 (5.3, 11.0) 8.7 (6.0, 13.4) 6.8 (5.1, 10.4) 0.010 10.4 (6.7, 16.1) 6.8 (5.1, 10.4) <0.001
 AST (U/L) 30 (20, 56) 33 (23, 68) 30 (20, 53) 0.174 36 (23, 64) 30 (20, 54) 0.240
 ALT (U/L) 20 (14, 37) 17 (12, 35) 21 (14, 37) 0.225 16 (11, 32) 21 (14, 38) 0.167
 TBIL (μmol/L) 14.8 (9.6, 23.0) 15.3 (10.3, 23.5) 14.3 (9.5, 22.7) 0.318 15.1 (9.6, 23.6) 14.7 (9.8, 22.9) 0.778
 DBIL (μmol/L) 6.4 (4.0, 10.6) 6.8 (4.4, 11.3) 6.1 (3.8, 10.2) 0.089 6.1 (4.3, 11.5) 6.4 (4.0, 10.4) 0.503
 K+ (mmol/L) 3.8 (3.5, 4.2) 3.9 (3.5, 4.4) 3.8 (3.5, 4.2) 0.252 4.0 (3.6, 4.4) 3.8 (3.5, 4.2) 0.050
 PaO2/FiO2 303 (262, 352) 285 (246, 328) 313 (273, 363) <0.001 286 (241, 328) 310 (268, 361) 0.007
Vital signs
 SBP (mmHg) 132 (119, 139) 122 (97, 135) 134 (125, 143) <0.001 122 (96, 135) 132 (122, 142) <0.001
 DBP (mmHg) 68 (65, 76) 63 (55, 70) 70 (66, 78) <0.001 65 ± 11 69 (65, 76) <0.001
 HR (times/min) 86 (78, 94) 87 (79, 106) 86 (78, 94) 0.009 86 (79, 106) 86 (78, 94) 0.024
Severity scores
 CURB65 2 (2, 3) 3 (3, 4) 2 (1, 3) <0.001 3 (3, 4) 2 (2, 3) <0.001
 CRB65 2 (1, 3) 3 (2, 3) 2 (1, 2) <0.001 3 (2, 3) 2 (1, 2) <0.001
 PSI 128 ± 40 157 ± 35 120 ± 38 <0.001 174 (150, 191) 121 ± 36 <0.001
 SOFA 3 (2, 5) 6 (4, 8) 3 (2, 4) <0.001 7 (6, 9) 3 (2, 4) <0.001
 qSOFA 2 (1, 2) 3 (2, 3) 1 (1, 2) <0.001 3 (2, 3) 1 (1, 2) <0.001
 Lactate (mmol/L) 1.4 (1.1, 2.1) 1.8 (1.3, 2.9) 1.3 (1.1, 1.8) <0.001 2.5 (1.6, 4.2) 1.3 (1.1, 1.8) <0.001

Data are presented as n, n (%), or median (QL, QU). CAP: community-acquired pneumonia; ED: emergency department; SCAP: severe community-acquired pneumonia; NSCAP: nonsevere community-acquired pneumonia; COPD: chronic obstructive pulmonary disease; CDVD: cardiovascular disease; CBVD: cerebrovascular disease; CRD: chronic renal disease; HBD: hepatobiliary disease; WBC: white blood cell; HGB: hemoglobin; HCT: hematocrit; PLT: platelet; ALB: albumin; CREA: creatinine; BUN: blood urea nitrogen; AST: aspartate aminotransferase; ALT: alanine aminotransferase; TBIL: total bilirubin; DBIL: direct bilirubin; SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; CURB65: confusion, urea > 7 mmol/L, respiratory rate ≥ 30/min, blood pressure < 90 mmHg systolic and/or ≤60 mmHg diastolic, and age ≥ 65 years; CRB65: confusion, respiratory rate ≥ 30/min, blood pressure < 90 mmHg systolic and/or ≤60 mmHg diastolic, and age ≥ 65 years; PSI: pneumonia severity index; SOFA: sequential organ failure assessment; qSOFA: quick sequential organ failure assessment.